24.90
price down icon0.28%   -0.07
after-market Dopo l'orario di chiusura: 24.51 -0.39 -1.57%
loading

Edgewise Therapeutics Inc Azioni (EWTX) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-06-30 2025-03-31 2024-09-30 2024-06-30 2024-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
7.29%
42.61
45.96 40.43 38.11 34.75
Operating Income/Loss
7.29%
-42.61
-45.96 -40.43 -38.11 -34.75
Income/Loss From Continuing Operations Before Tax
11.48%
-36.12
-40.80 -34.13 -31.50 -28.52
Income/Loss From Continuing Operations After Tax
11.48%
-36.12
-40.80 -34.13 -31.50 -28.52
Net Income/Loss
11.48%
-36.12
-40.80 -34.13 -31.50 -28.52
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
10.31%
104.94
95.13 93.81 93.52 87.57
Diluted Average Shares
10.31%
104.94
95.13 93.81 93.52 87.57
Basic Earnings Per Share
20.93%
-0.34
-0.43 -0.36 -0.34 -0.33
Diluted Earnings Per Share
20.93%
-0.34
-0.43 -0.36 -0.34 -0.33
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$106.87
price up icon 0.90%
$34.26
price up icon 1.87%
$118.64
price up icon 10.48%
$99.85
price up icon 1.01%
biotechnology ONC
$337.89
price up icon 5.47%
$175.97
price up icon 3.35%
Capitalizzazione:     |  Volume (24 ore):